Northland Capmk Upgrades Astera Labs (NASDAQ:ALAB) to Strong-Buy

Astera Labs (NASDAQ:ALAB) was upgraded by analysts at Northland Capmk from a “hold” rating to a “strong-buy” rating in a report issued on Monday,Zacks.com reports.

A number of other equities research analysts have also recently issued reports on the stock. Bank of America initiated coverage on shares of Astera Labs in a research report on Friday, October 3rd. They set a “neutral” rating and a $230.00 target price for the company. Roth Capital raised their price objective on shares of Astera Labs from $200.00 to $225.00 and gave the stock a “buy” rating in a report on Wednesday, November 5th. JPMorgan Chase & Co. boosted their target price on Astera Labs from $180.00 to $215.00 and gave the stock an “overweight” rating in a report on Wednesday, November 5th. Citigroup raised their price target on Astera Labs from $160.00 to $275.00 and gave the company a “buy” rating in a report on Wednesday, September 17th. Finally, Stifel Nicolaus lifted their price objective on Astera Labs from $185.00 to $200.00 and gave the company a “buy” rating in a research report on Wednesday, November 5th. One equities research analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and seven have given a Hold rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $184.82.

Astera Labs Trading Down 1.3%

Shares of ALAB opened at $139.52 on Monday. The stock has a market cap of $23.56 billion, a PE ratio of 125.69, a PEG ratio of 2.64 and a beta of 1.37. Astera Labs has a 1 year low of $47.13 and a 1 year high of $262.90. The stock has a 50 day simple moving average of $190.50 and a 200-day simple moving average of $145.33.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings results on Tuesday, November 4th. The company reported $0.49 EPS for the quarter, beating the consensus estimate of $0.39 by $0.10. Astera Labs had a return on equity of 13.48% and a net margin of 27.50%.The business had revenue of $230.58 million for the quarter, compared to analyst estimates of $206.42 million. During the same quarter in the previous year, the firm earned $0.23 EPS. Astera Labs’s quarterly revenue was up 103.9% on a year-over-year basis. Astera Labs has set its Q4 2025 guidance at 0.50-0.510 EPS. On average, sell-side analysts forecast that Astera Labs will post 0.34 EPS for the current fiscal year.

Insider Activity

In related news, General Counsel Philip Mazzara sold 10,000 shares of Astera Labs stock in a transaction dated Wednesday, October 1st. The stock was sold at an average price of $192.16, for a total value of $1,921,600.00. Following the completion of the sale, the general counsel directly owned 151,573 shares in the company, valued at $29,126,267.68. This trade represents a 6.19% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Jack R. Lazar sold 22,500 shares of the business’s stock in a transaction dated Wednesday, August 27th. The stock was sold at an average price of $178.42, for a total value of $4,014,450.00. Following the sale, the director directly owned 97,351 shares of the company’s stock, valued at $17,369,365.42. This represents a 18.77% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last ninety days, insiders sold 225,500 shares of company stock valued at $39,531,460. Company insiders own 12.50% of the company’s stock.

Institutional Investors Weigh In On Astera Labs

Institutional investors have recently modified their holdings of the business. Assetmark Inc. lifted its holdings in Astera Labs by 374.1% in the third quarter. Assetmark Inc. now owns 128 shares of the company’s stock valued at $25,000 after buying an additional 101 shares during the period. Wexford Capital LP bought a new stake in shares of Astera Labs during the 3rd quarter valued at $39,000. National Bank of Canada FI lifted its stake in shares of Astera Labs by 159.0% in the 3rd quarter. National Bank of Canada FI now owns 202 shares of the company’s stock valued at $39,000 after purchasing an additional 124 shares during the period. Pinpoint Asset Management Singapore Pte. Ltd. bought a new position in shares of Astera Labs in the 3rd quarter worth $47,000. Finally, Whittier Trust Co. acquired a new stake in shares of Astera Labs during the third quarter worth $55,000. Institutional investors and hedge funds own 60.47% of the company’s stock.

Astera Labs Company Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.